Detalles de la búsqueda
1.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499241
2.
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Blood
; 132(25): 2639-2642, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30266774
3.
Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma.
Blood
; 132(1): 40-48, 2018 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703778
4.
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 385(9980): 1853-62, 2015 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25796459
5.
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 21(9): 1605-11, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983043
6.
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Cancer
; 121(20): 3709-16, 2015 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26207349
7.
Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma.
Br J Haematol
; 189(3): e86-e90, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32048731
8.
Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.
Blood
; 122(24): 3871-8, 2013 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081656
9.
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
Oncologist
; 16(2): 197-206, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21273514
10.
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood
; 113(14): 3383-91, 2009 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-19015394
11.
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA
; 306(17): 1874-83, 2011 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-22045765
12.
Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience.
Bone Marrow Transplant
; 55(1): 172-181, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31481800
13.
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Clin Cancer Res
; 25(16): 5143-5155, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31253630
14.
The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 14(9 Suppl): 2-7, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18721774
15.
Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
Biol Blood Marrow Transplant
; 14(9 Suppl): 8-15, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18721775
16.
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biol Blood Marrow Transplant
; 14(2): 246-55, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18215785
17.
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
Br J Haematol
; 143(3): 395-403, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18759762
18.
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
J Clin Oncol
; 23(16): 3819-29, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15809448
19.
Liver transplant-associated graft-versus-host disease.
Transplantation
; 75(1): 118-26, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12544883
20.
Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases.
Int J Hematol
; 76 Suppl 1: 184-9, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12430851